• OPEN AN ACCOUNT
Indian Indices
Nifty
25,476.10 -46.40
(-0.18%)
Sensex
83,190.28 -345.80
( -0.41%)
Bank Nifty
57,213.55 -42.75
( -0.07%)
Nifty IT
38,680.85 -302.40
( -0.78%)
Global Indices
Nasdaq
44,477.29 215.52
(0.49%)
Dow Jones
6,283.97 37.45
(0.60%)
Hang Seng
39,601.95 -219.33
(-0.55%)
Nikkei 225
8,867.02 12.84
(0.15%)
Forex
USD-INR
85.73 -0.06
(-0.07%)
EUR-INR
100.55 -0.15
(-0.15%)
GBP-INR
116.58 -0.23
(-0.19%)
JPY-INR
0.59 0.00
(-0.73%)

EQUITY - MARKET SCREENER

Sandu Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524703
INE751D01014
43.495532
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
31.47
48.64
EPS(TTM)
Face Value()
Div & Yield %
1.6
10
0
 

As on: Jul 10, 2025 04:01 PM

Last Price() Net Change (%) Volume (Nos) P / E
49.60 -0.75 778 31.47
Stock Price Details
Open Price() 49.00
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 50.49
Today's Low () 49.00
52-Week High () 69.5
152-Week Low () 43.75
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.00
Eps 1.6
Book Value 43.495532
Market Cap (.Cr) 48.64
Face Value 10
Market Lot 1
AGM Date Sep
Book Closure Date Sep
ISIN No. INE751D01014


News
Sandu Pharmaceuticals Ltd - Closure of Trading Window
Sandu Pharmaceuticals consolidated net profit declines 44.07% in the March 2025 quarter
Board of Sandu Pharmaceuticals recommends final dividend
Sandu Pharmaceuticals Ltd - Disclosure Under Regulation 30 Read With Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Sandu Pharmaceuticals to table results
Sandu Pharmaceuticals Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Sandu Pharmaceuticals Ltd - Disclosure In Terms Of Regulation 31(4) Of The SEBI (Substantial Acquisition Of Shares And Takeover) Regulations 2011
Sandu Pharmaceuticals Ltd - Announcement Under Reg 30-Update-Clarification To Your Email Dated 18.02.2025 On Non-Compliance With Regulation 33 Of SEBI (LODR) Regulations 2015 For The Period Ended December 31 2024.
Sandu Pharmaceuticals standalone net profit rises 166.67% in the December 2024 quarter
Sandu Pharmaceuticals Ltd - Announcement Under Reg 30 Of SEBI (LODR)-Update-Intimation Inrespect Of The Order Received From Government Of Maharashtra Department Of Goods And Service Tax
More
Corporate Details
Incoporation Year   : 1985
Chairman : Balaram Vishwanathan
Bussiness Group :
Registered Office
Sandu Pharmaceuticals Ltd
Plot No 25/26/29 & 30,
Pilerne Indl Estate Marra Bard,
Bardez,
Goa-403511
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:N.A.
Fax:N.A.
Fax:91-22-66317458
E-Mail : corp.sec@sandu.in
URL : http://www.sandu.in


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
No Data Found...!
No Data Found...!
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi